Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 9, Pages 2551
Publisher
MDPI AG
Online
2021-04-28
DOI
10.3390/molecules26092551
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents
- (2020) Abdallah Hamze et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Theranostic MRI liposomes for magnetic targeting and ultrasound triggered release of the antivascular CA4P
- (2020) Caroline J. Thébault et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis of Combretastatin A-4 and 3′-Aminocombretastatin A-4 derivatives with Aminoacid Containing Pendants and Study of their Interaction with Tubulin and as Downregulators of the VEGF, hTERT and c-Myc Gene Expression
- (2020) Raül Agut et al. MOLECULES
- Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice
- (2020) Vera Labitzky et al. Cancers
- Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation
- (2020) Yewei Liu et al. Diagnostics
- Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease
- (2020) Chengyan Chu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Colchicine Alkaloids, and Synthetic Analogues: Current Progress and Perspectives
- (2020) Iuliia Alexandrovna Gracheva et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
- (2020) Blake A. Winn et al. JOURNAL OF NATURAL PRODUCTS
- Oxygen-enhanced optoacoustic tomography reveals the effectiveness of targeting heme and oxidative phosphorylation at normalizing tumor vascular oxygenation
- (2020) Poorva Ghosh et al. CANCER RESEARCH
- Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study
- (2020) Krishnansu S. Tewari et al. GYNECOLOGIC ONCOLOGY
- Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents
- (2020) Michael R. Horsman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications
- (2020) Gökçe Şeker Karatoprak et al. MOLECULES
- Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption
- (2020) Needa A. Virani et al. PLoS One
- Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
- (2020) Sheng Hong et al. Science Advances
- Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide
- (2020) Alexandra M. Mowday et al. Cancers
- High Sensitivity In Vivo Imaging of Cancer Metastasis Using a Near-Infrared Luciferin Analogue seMpai
- (2020) Jun Nakayama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Use of photoacoustic imaging for monitoring vascular disrupting cancer treatments
- (2020) Muhannad N Fadhel et al. Journal of Biophotonics
- Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin
- (2020) Andres M. Arias Lorza et al. Scientific Reports
- Evaluating online filtering algorithms to enhance dynamic multispectral optoacoustic tomography
- (2020) Devin O’Kelly et al. Photoacoustics
- Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer
- (2020) Natalie J. Serkova et al. CANCER RESEARCH
- Vascular disrupting agents in cancer therapy
- (2020) Ryszard Smolarczyk et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Multifunctional drug-loaded micelles encapsulated in thermo-sensitive hydrogel for in vivo local cancer treatment: Synergistic effects of anti-vascular and immuno-chemotherapy
- (2020) Haile Fentahun Darge et al. CHEMICAL ENGINEERING JOURNAL
- The effect of flow on blood oxygen level dependent (R* 2 ) MRI of orthotopic lung tumors
- (2019) Heling Zhou et al. MAGNETIC RESONANCE IN MEDICINE
- Translating preclinical MRI methods to clinical oncology
- (2019) David A. Hormuth et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Volumetric optoacoustic imaging unveils high-resolution patterns of acute and cyclic hypoxia in a murine model of breast cancer
- (2019) Avihai Ron et al. CANCER RESEARCH
- Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization
- (2019) Haichan Niu et al. JOURNAL OF MEDICINAL CHEMISTRY
- CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans
- (2019) Hanwei Chen et al. MAGNETIC RESONANCE IN MEDICINE
- Oxygen‐sensitive MRI assessment of tumor response to hypoxic gas breathing challenge
- (2019) Donghan M. Yang et al. NMR IN BIOMEDICINE
- Optimizing live‐animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID‐NSG mice
- (2019) Sangyub Kim et al. PROSTATE
- Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics
- (2019) Jason H. Gill et al. PHARMACOLOGY & THERAPEUTICS
- Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer
- (2019) M. K. Ravoori et al. Scientific Reports
- Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients
- (2019) Eline Abma et al. Scientific Reports
- Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate
- (2019) Meng Gao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Longitudinal photoacoustic imaging of the pharmacodynamic effect of vascular targeted therapy on tumors
- (2019) Sean Peter Johnson et al. CLINICAL CANCER RESEARCH
- Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies
- (2019) Janine Rennert et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Non-invasive Bioluminescence Monitoring of Hepatocellular Carcinoma Therapy in an HCR Mouse Model
- (2019) Zhu Zhao et al. Frontiers in Oncology
- In vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation
- (2019) Zijian Deng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment
- (2019) Na Shen et al. NANO LETTERS
- Effects of Photodynamic Therapy with Redaporfin on Tumor Oxygenation and Blood Flow in a Lung Cancer Mouse Model
- (2019) Malwina Karwicka et al. Scientific Reports
- Nanoparticles for multimodal antivascular therapeutics: Dual drug release, photothermal and photodynamic therapy
- (2019) Juan L. Paris et al. Acta Biomaterialia
- Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis
- (2018) Shugo Yamashita et al. BIOMATERIALS
- Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI
- (2018) Stefanie J. Hectors et al. CANCER RESEARCH
- Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents
- (2018) Dongjian Zhang et al. Contrast Media & Molecular Imaging
- The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats
- (2018) Yewei Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Tomographic breathing detection: a method to noninvasively assess in situ respiratory dynamics
- (2018) Devin O’Kelly et al. JOURNAL OF BIOMEDICAL OPTICS
- Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters
- (2018) Su Yeon Ahn et al. PLoS One
- Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound
- (2018) Pingyu Zhang et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers
- (2018) E. Abma et al. Veterinary and Comparative Oncology
- Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers
- (2018) Ye-Wei Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice
- (2018) Volker Neuschmelting et al. Theranostics
- Oxygen-enhanced and dynamic contrast-enhanced optoacoustic tomography provide surrogate biomarkers of tumour vascular function, hypoxia and necrosis.
- (2018) Michal R Tomaszewski et al. CANCER RESEARCH
- Noninvasive Anatomical and Functional Imaging of Orthotopic Glioblastoma Development and Therapy using Multispectral Optoacoustic Tomography
- (2018) Ghayathri Balasundaram et al. Translational Oncology
- Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents
- (2018) Casey J. Maguire et al. MedChemComm
- Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy
- (2018) Andrew W. Brown et al. ChemMedChem
- Methods to Label, Image, and Analyze the Complex Structural Architectures of Microvascular Networks
- (2018) Bruce A. Corliss et al. MICROCIRCULATION
- The development and use of vascular targeted therapy in ovarian cancer
- (2017) Dana M. Chase et al. GYNECOLOGIC ONCOLOGY
- Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents
- (2017) Minfeng Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Gadolinium-based contrast agents: A comprehensive risk assessment
- (2017) Tyler J. Fraum et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- In Vivo and Mechanistic Studies on Antitumor Lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and Its Modification as a Novel Class of Tubulin-Binding Tumor-Vascular Disrupting Agents
- (2017) Mu-Tian Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of Precision in Optoacoustic Tomography for Preclinical Imaging in Living Subjects
- (2017) James Joseph et al. JOURNAL OF NUCLEAR MEDICINE
- Inhibiting Solid Tumor Growth In Vivo by Non-Tumor-Penetrating Nanomedicine
- (2017) Shixian Lv et al. Small
- Evaluation of Antivascular Combretastatin A4 P Efficacy Using Supersonic Shear Imaging Technique of Ectopic Colon Carcinoma CT26
- (2017) Johanne Seguin et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent
- (2017) Linda Rickardson et al. Drug Design Development and Therapy
- The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells
- (2017) Sanchareeka Dey et al. Oncotarget
- Tumor physiological changes during hypofractionated stereotactic body radiation therapy assessed using multi-parametric magnetic resonance imaging
- (2017) Heling Zhou et al. Oncotarget
- Oxygen breathing challenge- the simplest theranostic
- (2017) Ralph P. Mason Theranostics
- Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy
- (2017) Andrew B. Satterlee et al. Theranostics
- Oxygen Enhanced Optoacoustic Tomography (OE-OT) Reveals Vascular Dynamics in Murine Models of Prostate Cancer
- (2017) Michal R Tomaszewski et al. Theranostics
- Tumor Neovasculature-Targeted APRPG-PEG-PDLLA/MPEG-PDLLA Mixed Micelle Loading Combretastatin A-4 for Breast Cancer Therapy
- (2017) Ying Hao et al. ACS Biomaterials-Science & Engineering
- Tumor Neovasculature-Targeted APRPG-PEG-PDLLA/MPEG-PDLLA Mixed Micelle Loading Combretastatin A-4 for Breast Cancer Therapy
- (2017) Ying Hao et al. ACS Biomaterials Science & Engineering
- A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial.
- (2017) J. A. Sosa et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site
- (2017) Xin Zhai et al. Scientific Reports
- (−)-Rhazinilam and the diphenylpyridazinone NSC 613241: Two compounds inducing the formation of morphologically similar tubulin spirals but binding apparently to two distinct sites on tubulin
- (2016) Ruoli Bai et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- CA-1H, a novel oxazole bearing analogue of combretastatin A-4, disrupts the tumor vasculatures and inhibits the tumor growth via inhibiting tubulin polymerization
- (2016) Fuguo Han et al. BIOMEDICINE & PHARMACOTHERAPY
- Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
- (2016) Laxman Devkota et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling
- (2016) S Peter Johnson et al. BRITISH JOURNAL OF CANCER
- Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors
- (2016) Christin Glowa et al. CANCER LETTERS
- Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response
- (2016) Derek A. White et al. CANCER LETTERS
- Abstract 4194: Assessment of novel benzosuberene-based vascular disrupting agents (VDA) on diverse tumor lines
- (2016) Li Liu et al. CANCER RESEARCH
- Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells
- (2016) Wendan Wang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology
- (2016) L. R. McNally et al. CLINICAL CANCER RESEARCH
- Early investigational tubulin inhibitors as novel cancer therapeutics
- (2016) Kunal Nepali et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bioluminescence Tomography–Guided Radiation Therapy for Preclinical Research
- (2016) Bin Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth
- (2016) María-Jesús Pérez-Pérez et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas
- (2016) Margaret Folaron et al. MOLECULAR IMAGING AND BIOLOGY
- Contrast agents for molecular photoacoustic imaging
- (2016) Judith Weber et al. NATURE METHODS
- Monitoring Vascular Disrupting Therapy in a Rabbit Liver Tumor Model: Relationship between Tumor Perfusion Parameters at IVIM Diffusion-weighted MR Imaging and Those at Dynamic Contrast-enhanced MR Imaging
- (2016) Ijin Joo et al. RADIOLOGY
- Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation—Chemoembolization Therapy in Rats
- (2016) Junjie Li et al. RADIOLOGY
- A cooperative polymeric platform for tumor-targeted drug delivery
- (2016) Wantong Song et al. Chemical Science
- Synthesis and biological evaluation of benzocyclooctene-based and indene-based anticancer agents that function as inhibitors of tubulin polymerization
- (2016) Christine A. Herdman et al. MedChemComm
- Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
- (2016) Wenjie Liang et al. Oncotarget
- Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer
- (2016) Peng Xu et al. Oncotarget
- The Blood Flow Shutdown Induced by Combretastatin A4 Impairs Gemcitabine Delivery in a Mouse Hepatocarcinoma
- (2016) Anne-Catherine Fruytier et al. Frontiers in Pharmacology
- Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
- (2016) Katelyn Bothwell et al. Cancers
- Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization
- (2015) Christine A. Herdman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
- (2015) Tracy E. Strecker et al. CANCER LETTERS
- Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts
- (2015) Li Liu et al. CANCER LETTERS
- Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
- (2015) J. P. B. O'Connor et al. CANCER RESEARCH
- A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
- (2015) S. Pal et al. CLINICAL CANCER RESEARCH
- Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
- (2015) Ya-Ting Ji et al. CURRENT MEDICINAL CHEMISTRY
- Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1
- (2015) Charles W. Kimbrough et al. JOURNAL OF SURGICAL RESEARCH
- Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Jean-Yves Blay et al. LANCET ONCOLOGY
- O2-sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models
- (2015) Scott C. Beeman et al. MAGNETIC RESONANCE IN MEDICINE
- Monitoring Combretastatin A4-induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE-MRI
- (2015) Florence Colliez et al. MAGNETIC RESONANCE IN MEDICINE
- Dynamic oxygen challenge evaluated by NMRT1andT2* - insights into tumor oxygenation
- (2015) Dawen Zhao et al. NMR IN BIOMEDICINE
- MRI-Tracked Tumor Vascular Changes in the Hours after Single-Fraction Irradiation
- (2015) Stephen L. Brown et al. RADIATION RESEARCH
- Photoacoustic Imaging of Vascular Hemodynamics: Validation with Blood Oxygenation Level–Dependent MR Imaging
- (2015) Laurie J. Rich et al. RADIOLOGY
- Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions
- (2015) Wantong Song et al. Small
- Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer
- (2015) James Kalmuk et al. Oncotarget
- Prediction of Tumor Recurrence and Therapy Monitoring Using Ultrasound-Guided Photoacoustic Imaging
- (2015) Srivalleesha Mallidi et al. Theranostics
- Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography
- (2014) J Li et al. BRITISH JOURNAL OF CANCER
- The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer
- (2014) Daniel J Inglis et al. CANCER BIOLOGY & THERAPY
- Use of labeled tomato lectin for imaging vasculature structures
- (2014) Richard T. Robertson et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4
- (2014) A.-C. Fruytier et al. NMR IN BIOMEDICINE
- In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors
- (2014) Jennifer A. Lee et al. Biomedical Optics Express
- Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
- (2014) Heling Zhou et al. Jove-Journal of Visualized Experiments
- Novel Isoprenoyl Nanoassembled Prodrug for Paclitaxel Delivery
- (2013) Simona Mura et al. BIOCONJUGATE CHEMISTRY
- New cytotoxic benzosuberene analogs. Synthesis, molecular modeling and biological evaluation
- (2013) Zecheng Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Vascular-disrupting agents in oncology
- (2013) Monica M Mita et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy
- (2013) VASU TUMATI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Vascular disrupting effect of CKD-516: preclinical study using DCE-MRI
- (2013) Kyung Won Kim et al. INVESTIGATIONAL NEW DRUGS
- Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent
- (2013) Mallinath B. Hadimani et al. JOURNAL OF NATURAL PRODUCTS
- Correlations of noninvasive BOLD and TOLD MRI with pO2and relevance to tumor radiation response
- (2013) Rami R. Hallac et al. MAGNETIC RESONANCE IN MEDICINE
- Vascular priming enhances chemotherapeutic efficacy against head and neck cancer
- (2013) Margaret Folaron et al. ORAL ONCOLOGY
- Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Noninvasive Evaluation of Vascular Disrupting Treatment on Rabbit Liver Tumors
- (2013) Haibo Shao et al. PLoS One
- Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
- (2013) Marta Cesca et al. Frontiers in Oncology
- The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts
- (2012) Dušan Milanović et al. BMC CANCER
- Combretastatin A-4 Phosphate Affects Tumor Vessel Volume and Size Distribution as Assessed Using MRI-Based Vessel Size Imaging
- (2012) T. Nielsen et al. CLINICAL CANCER RESEARCH
- Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors
- (2012) Dan M. Patterson et al. CLINICAL CANCER RESEARCH
- Combination of vascular disrupting agents and ionizing radiation
- (2012) Céline Clémenson et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models
- (2012) Céline Clémenson et al. INVESTIGATIONAL NEW DRUGS
- In vivo preclinical photoacoustic imaging of tumor vasculature development and therapy
- (2012) Jan Laufer et al. JOURNAL OF BIOMEDICAL OPTICS
- Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent
- (2012) M Benezra et al. LEUKEMIA
- MRI measurements of vessel calibre in tumour xenografts: Comparison with vascular corrosion casting
- (2012) Jake S. Burrell et al. MICROVASCULAR RESEARCH
- Bioluminescence Imaging Correlates with Tumor Serum Marker, Organ Weights, Histology, and Human DNA Levels during Treatment of Orthotopic Tumor Xenografts with Antibodies
- (2012) Thomas Poeschinger et al. MOLECULAR IMAGING AND BIOLOGY
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
- (2012) Li Liu et al. PLoS One
- Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in Tumors
- (2012) Mustafa K. Alhasan et al. PLoS One
- An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity
- (2012) Rajendra P. Tanpure et al. MedChemComm
- A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
- (2011) Alejandro D. Ricart et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Arsenic Trioxide Treatment Decreases the Oxygen Consumption Rate of Tumor Cells and Radiosensitizes Solid Tumors
- (2011) C. Diepart et al. CANCER RESEARCH
- Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
- (2011) D. Rischin et al. CLINICAL CANCER RESEARCH
- Diffusion-weighted MR imaging allows monitoring the effect of combretastatin A4 phosphate on rabbit implanted VX2 tumor model: 12-Day dynamic results
- (2011) Haibo Shao et al. EUROPEAN JOURNAL OF RADIOLOGY
- A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment
- (2011) Ralph P. Mason et al. Integrative Biology
- Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts
- (2011) Simon Walker-Samuel et al. INTERNATIONAL JOURNAL OF CANCER
- Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation
- (2011) Lotte B. Bertelsen et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome
- (2011) Dawen Zhao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice
- (2011) Abigail F. Welford et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma
- (2011) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature
- (2010) Yanping Luo et al. ANTI-CANCER DRUGS
- Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent
- (2010) J D Lickliter et al. BRITISH JOURNAL OF CANCER
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin and paclitaxel in patients with advanced cancer
- (2010) G J Rustin et al. BRITISH JOURNAL OF CANCER
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents
- (2010) Dietmar W. Siemann CANCER TREATMENT REVIEWS
- Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas
- (2010) M. M. Mita et al. CLINICAL CANCER RESEARCH
- Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies
- (2010) Chryso Kanthou et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Detection of Tumor Response to a Vascular Disrupting Agent by Hyperpolarized 13C Magnetic Resonance Spectroscopy
- (2010) S. E. Bohndiek et al. MOLECULAR CANCER THERAPEUTICS
- Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial
- (2009) Dow-Mu Koh et al. EUROPEAN RADIOLOGY
- A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
- (2009) Dietmar W Siemann et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Treatment of Rodent Liver Tumor With Combretastatin A4 Phosphate
- (2009) Huaijun Wang et al. INVESTIGATIVE RADIOLOGY
- MRI-Based Characterization of Vascular Disruption by 5,6-Dimethylxanthenone-Acetic Acid in Gliomas
- (2009) Mukund Seshadri et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy
- (2008) Madhavi Sriram et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI
- (2008) Dawen Zhao et al. FASEB JOURNAL
- Nephrogenic Systemic Fibrosis: A Chemical Perspective
- (2008) Neil M. Rofsky et al. RADIOLOGY
- Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer
- (2008) Matteo Bellone et al. TRENDS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now